Breast Biopsy tests are applicable in the detection of breast cancer. They help diagnose lumps in breasts and other abnormalities through physical examination. Besides these, breast biopsy tests are found useful in preventive checkups for breast cancer. Various systems can be used to perform this procedure including imaging guidance systems and needle-based systems. Breast biopsy is broadly used in hospitals, ASCs, research centers, and others.
To get full research report at : https://goo.gl/7Jdnv1
3D Digital Mammogram to Witness Significant Rise in Demand
The biopsy procedures need guidance systems to identify the lump or abnormality in the breast area. The breast biopsy imaging guidance systems include mammography-guided stereotactic, magnetic resonance guided, ultrasound-guided, among others that help with the procedure of identifying and locating the existence of abnormal cell growths. These digitally advanced breast biopsy imaging guidance systems are extensively utilized to capture accurate images of breast. These systems are capable of detecting even the small cancerous cells. Among the aforementioned types of guidance systems, mammography-guided system is anticipated to contribute to the most significant share in the sector. Adoption of breast biopsy imaging guidance system has witnessed impressive rise in recent years. It is expected to drive the demand due to rapid development of next generation breast biopsy imaging systems.
The 3D digital mammogram makes it easier to capture a digital image of the breast for identification of even the small-sized cancerous cells, which is usually not possible using 2D mammography. For instance, Brevera breast biopsy system with CorLumina imaging technology is the recent innovation introduced by Hologic Inc. It is a real-time verification system, which supports 2D and 3D breast biopsy procedures. The system can offer an improved accuracy level, which helps the physicians in making accurate diagnosis. The real-time images deliver exact and crucial information at the point of concern. In addition, it can also provide a series of procedures such as acquiring tissues, capturing real-time images, identifying and verifying the sample and handling the post-biopsy at an advanced level all in a single unit.
According to a report available on Radiant Insights, Inc.; the worldwide breast biopsy market is anticipated to grow rapidly by 2021. Important factors like growing incidence of breast cancer in women, awareness regarding cancer screening programs, and demand for minimally invasive breast biopsy procedures can impel the market during the forecast period (2017 to 2021).
However, limited awareness regarding advanced breast biopsy techniques and the risks associated with the procedure can restrain the market growth to a certain extent.
Asia Pacific is estimated to grow significantly during the forecast period, due to flourishing healthcare infrastructure. Some of the leading companies operating in the market for breast biopsy include Leica Biosystems, C.R. Bard, Hologic, and BD.
Download free sample request at :